305 related articles for article (PubMed ID: 16631737)
1. Immune modulation by mesenchymal stem cells.
Rasmusson I
Exp Cell Res; 2006 Jul; 312(12):2169-79. PubMed ID: 16631737
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation by mesenchymal stem cells and clinical experience.
Le Blanc K; Ringdén O
J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
[TBL] [Abstract][Full Text] [Related]
3. Immune plasticity of bone marrow-derived mesenchymal stromal cells.
Stagg J; Galipeau J
Handb Exp Pharmacol; 2007; (180):45-66. PubMed ID: 17554504
[TBL] [Abstract][Full Text] [Related]
4. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N
Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
Zhao ZG; Li WM; Chen ZC; You Y; Zou P
Immunol Invest; 2008; 37(7):726-39. PubMed ID: 18821219
[TBL] [Abstract][Full Text] [Related]
6. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
[TBL] [Abstract][Full Text] [Related]
9. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells: a new strategy for immunosuppression?
Uccelli A; Pistoia V; Moretta L
Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
[TBL] [Abstract][Full Text] [Related]
11. Immune regulation by mesenchymal stem cells: two sides to the coin.
Stagg J
Tissue Antigens; 2007 Jan; 69(1):1-9. PubMed ID: 17212702
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
13. Immune properties of mesenchymal stem cells.
Sotiropoulou PA; Papamichail M
Methods Mol Biol; 2007; 407():225-43. PubMed ID: 18453259
[TBL] [Abstract][Full Text] [Related]
14. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells.
Groh ME; Maitra B; Szekely E; Koç ON
Exp Hematol; 2005 Aug; 33(8):928-34. PubMed ID: 16038786
[TBL] [Abstract][Full Text] [Related]
15. A role for mesenchymal stem cells in the control of graft-versus-host disease.
Cohen JL; Sudres M
Transplantation; 2009 May; 87(9 Suppl):S53-4. PubMed ID: 19424007
[TBL] [Abstract][Full Text] [Related]
16. Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes.
Maccario R; Moretta A; Cometa A; Montagna D; Comoli P; Locatelli F; Podestà M; Frassoni F
Biol Blood Marrow Transplant; 2005 Dec; 11(12):1031-2. PubMed ID: 16338626
[No Abstract] [Full Text] [Related]
17. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells.
Prigione I; Benvenuto F; Bocca P; Battistini L; Uccelli A; Pistoia V
Stem Cells; 2009 Mar; 27(3):693-702. PubMed ID: 19096038
[TBL] [Abstract][Full Text] [Related]
18. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
Poncelet AJ; Vercruysse J; Saliez A; Gianello P
Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
[TBL] [Abstract][Full Text] [Related]
19. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance.
Wang Q; Sun B; Wang D; Ji Y; Kong Q; Wang G; Wang J; Zhao W; Jin L; Li H
Scand J Immunol; 2008 Dec; 68(6):607-15. PubMed ID: 18959624
[TBL] [Abstract][Full Text] [Related]
20. Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells.
Li C; Zhang W; Jiang X; Mao N
Cell Tissue Res; 2007 Dec; 330(3):437-46. PubMed ID: 17899199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
